{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:27:07Z","timestamp":1787020027766,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous studies have shown that tuberculosis (TB) is a risk factor for chronic airflow limitation. Chronic obstructive pulmonary disease (COPD) is recognized as the result of chronic inflammation, usually related to noxious particles. Post-TB airflow obstruction and tobacco-related COPD have the same functional pathway characterized by persistent airflow limitation. We sought to compare the profile of 29 cytokines in the sputum of subjects with post-TB airflow obstruction and those with COPD related to tobacco.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The forced expiratory volume in the first second (FEV1) and forced expiratory volume\/forced vital capacity (FEV\/FVC) ratio were lower in the COPD patients with the history of smoking compared to the post-TB airflow obstruction subgroup. The stages of the disease were more advanced in COPD \/ tobacco patients.<\/jats:p>\n                    <jats:p>\n                      Among the cytokines, IL-1\u03b1, IL-1\u03b2, MIP-1\u03b2, sCD40L and VEGF levels were higher in COPD patients, compared to the controls with\n                      <jats:italic>p<\/jats:italic>\n                      values \u200b\u200bof 0.003, 0.0001, 0.03, 0.0001 and 0.02 respectively. When the two COPD subgroups were compared, IL-1\u03b1, IL-6, TNF-\u03b1 and IL-8 levels were higher in the COPD patients with the history of tobacco compared to the COPD patients with the history of TB with\n                      <jats:italic>p<\/jats:italic>\n                      -values \u200b\u200bof 0.031, 0.05, 0.021 and 0.016, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>COPD related to tobacco is more severe than post-TB airflow obstruction. The pathogenesis of post-TB airflow obstruction appears to involve the cytokines IL-1RA, IL-1\u03b1, IL-1\u03b2, IL-17, GRO and sCD40L, while COPD related to tobacco involves more cytokines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12865-020-00381-w","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T01:09:07Z","timestamp":1601514547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-7375","authenticated-orcid":false,"given":"Elise","family":"Guiedem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Walter","family":"Pefura-Yone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Mondinde","family":"Ikomey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line Nguefeu","family":"Nkenfou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Mesembe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbanyamsig Mispa","family":"Yivala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bih Hycenta","family":"Chendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme Brendon","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novel Njweipi","family":"Chegou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Claire Assoumou","family":"Okomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"381_CR1","doi-asserted-by":"crossref","unstructured":"Aubier M, Marthan R, Berger P, Chambellan A, Chanez P, Aguilaniu B. BPCO et inflammation: mise au point par un groupe d\u2019experts. Les m\u00e9canismes de l\u2019inflammation et du remodelage. Revue des Maladies Respiratoires. Elsevier Masson. 2010;27:1254-66.","DOI":"10.1016\/j.rmr.2010.10.004"},{"key":"381_CR2","volume-title":"Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease","author":"GOLD","year":"2019","unstructured":"GOLD: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2019. http:\/\/goldcopd.org\/wp-content\/uploads. Accessed 10 Apr 2020."},{"issue":"3","key":"381_CR3","doi-asserted-by":"publisher","first-page":"e1000220","DOI":"10.1371\/journal.pmed.1000220","volume":"7","author":"PJ Barnes","year":"2010","unstructured":"Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010;7(3):e1000220. https:\/\/doi.org\/10.1371\/journal.pmed.1000220.","journal-title":"PLoS Med"},{"key":"381_CR4","doi-asserted-by":"publisher","first-page":"209S","DOI":"10.1378\/chest.121.5_suppl.209S","volume":"121","author":"WI Boer","year":"2002","unstructured":"Boer WI. Cytokines and therapy in COPD: a promising combination? CHEST. 2002;121:209S\u201318S.","journal-title":"CHEST."},{"key":"381_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","volume":"370","author":"AS Buist","year":"2007","unstructured":"Buist AS, Burnie MN, Vollmer WM. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007;370:741\u201350.","journal-title":"Lancet."},{"key":"381_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1440-1843.2010.01749.x","volume":"15","author":"TS Jordan","year":"2010","unstructured":"Jordan TS, Spencer EM, Davies P. Tuberculosis, bronchiectasis and chronic airflow obstruction. Respirology. 2010;15:623\u20138.","journal-title":"Respirology."},{"key":"381_CR7","doi-asserted-by":"publisher","first-page":"e37978","DOI":"10.1371\/journal.pone.0037978","volume":"7","author":"CH Lee","year":"2012","unstructured":"Lee CH, Lee MC, Lin HH, et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One. 2012;7:e37978.","journal-title":"PLoS One"},{"key":"381_CR8","unstructured":"Daniel L, Ciavaglia CE, Alberto NJ, Katherine WA, O\u2019Donnell ED. Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment. Expert Rev Respir Med. 2014;1\u201319. ISSN 1747-6348."},{"issue":"5","key":"381_CR9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4103\/lungindia.lungindia_183_17","volume":"34","author":"NK Jain","year":"2017","unstructured":"Jain NK. Chronic obstructive pulmonary disease and tuberculosis. Lung India. 2017;34(5):468\u20139.","journal-title":"Lung India"},{"key":"381_CR10","doi-asserted-by":"publisher","first-page":"PA680","DOI":"10.1183\/13993003","volume":"46","author":"H Gunen","year":"2015","unstructured":"Gunen H, Yakar HI, ErkanPehlivan PA, Aydogan S, Babalik A, Selvi \u00dc, T\u00fclayYarkin BA. Role of tuberculosis in COPD. Eur Respir J. 2015;46:PA680. https:\/\/doi.org\/10.1183\/13993003.","journal-title":"Eur Respir J"},{"key":"381_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0140-6736(07)61377-4","volume":"370","author":"S Buist","year":"2007","unstructured":"Buist S. Global burden of COPD: risk factors, prevalence and future trends. Lancet. 2007;370:765\u201373.","journal-title":"Lancet."},{"key":"381_CR12","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1164\/rccm.200906-0876OC","volume":"180","author":"B Celli","year":"2009","unstructured":"Celli B, Decramer M, Kesten S, Liu D, Mehra S, et al. Mortality in the 4 year trial of tiotropium (UPLIFT) in patients with COPD. Am J Respir Crit Care Med. 2009;180:948\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"381_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1165\/ajrcmb.23.4.3959","volume":"23","author":"C Rusznak","year":"2000","unstructured":"Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, et al. Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. Am J Respir Cell MolBiol. 2000;23:530\u20136.","journal-title":"Am J Respir Cell MolBiol"},{"issue":"12","key":"381_CR14","doi-asserted-by":"publisher","first-page":"e28457","DOI":"10.1371\/journal.pone.0028457","volume":"6","author":"FM Botelho","year":"2011","unstructured":"Botelho FM, Bauer CMT, Finch D, Nikota JK, Zavitz CCJ, Kelly A, Lambert KN, Piper S, Foster ML, Goldring JJP, Wedzicha JA, Bassett J, Bramson J, YoichiroIwakura MS, Kolbeck R, Coyle AJ, Humbles AA, Stampfli MR. IL 1a\/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS ONE. 2011;6(12):e28457.","journal-title":"PLoS ONE"},{"issue":"1","key":"381_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/rheumatology\/40.1.62","volume":"40","author":"G Cunnane","year":"2001","unstructured":"Cunnane G, Madigan A, Murphy E, FitzGerald O, Bresnihan B. The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis. Rheumatology. 2001;40(1):62\u20139.","journal-title":"Rheumatology."},{"issue":"2","key":"381_CR16","first-page":"6","volume":"11","author":"M Esmaeil","year":"2012","unstructured":"Esmaeil M, Ian MA, Hamed S, Mohammad RM, Gert F. Role of P2X7 receptors in release of IL-1\u03b2: a possible mediator of pulmonary inflammation. NRITLD. 2012;11(2):6\u201311.","journal-title":"NRITLD."},{"key":"381_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1378\/chest.09-1435","volume":"137","author":"KB Lam","year":"2010","unstructured":"Lam KB, Jiang CQ, Jordan RE, et al. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou biobank cohort study. Chest. 2010;137:593\u2013600.","journal-title":"Chest."},{"key":"381_CR18","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/ard.61.11.960","volume":"61","author":"DS Hallegua","year":"2002","unstructured":"Hallegua DS, Weisman MH. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis. 2002;61:960\u20137.","journal-title":"Ann Rheum Dis"},{"key":"381_CR19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.rmed.2005.08.022","volume":"100","author":"SH Suleyman","year":"2006","unstructured":"Suleyman SH, Hakan G, Le Vent CM, Aysun BK, Ismail T. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med. 2006;100:846\u201354.","journal-title":"Respir Med"},{"key":"381_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/thorax.58.7.573","volume":"58","author":"M Profita","year":"2003","unstructured":"Profita M, Chiappara G, Mirabella F, Di Giorgi R, Chimenti L, Costanzo G, Riccobono L, Bellia V, Bousquet J, Vignola AM. Effect of cilomilast (Ariflo) on TNF-a, IL-8, and GM-CSF release by airway cells of patients with COPD. Thorax. 2003;58:573\u20139.","journal-title":"Thorax"},{"issue":"12","key":"381_CR21","first-page":"5324","volume":"7","author":"X-N Li","year":"2014","unstructured":"Li X-N, Xue P, Dong Q. Imbalances of Th17 and Treg cells and their respective cytokines in COPD patients by disease stage. Int J Clin Exp Med. 2014;7(12):5324\u20139.","journal-title":"Int J Clin Exp Med"},{"key":"381_CR22","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1164\/ajrccm.156.5.9609138","volume":"156","author":"SL Huang","year":"1997","unstructured":"Huang SL, Su CH, Chang SC. Tumor necrosis factor-\u03b1 gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med. 1997;156:1436\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"381_CR23","first-page":"1035","volume":"28","author":"MC Bonnet","year":"2012","unstructured":"Bonnet MC, Bagot M, Bensussan A. Anticorps monoclonaux ciblant l\u2019IL-17A ou son r\u00e9cepteur dans le psoriasis : Une nouvelle approche th\u00e9rapeutique ? Med Sci. 2012;28(12):1035\u20137.","journal-title":"Med Sci"},{"key":"381_CR24","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","volume":"366","author":"KA Papp","year":"2012","unstructured":"Papp KA, Leonardi C, Menter A. Brodalumab, et al. an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012;366:1181\u20139.","journal-title":"N Engl J Med"},{"key":"381_CR25","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"Leonardi C, Matheson R, Zachariae C, et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med. 2012;366:1190\u20139.","journal-title":"N Engl J Med"},{"key":"381_CR26","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.4049\/jimmunol.164.5.2650","volume":"164","author":"NM Bless","year":"2000","unstructured":"Bless NM, Huber-Lang M, Guo R, Warner RL, Schmal H, Czermak BJ, Shanley TP, Crouch D, Lentsch AB, Sarma V, Mulligan MS, Friedl HP, Ward PA. Role of CC chemokines (macrophages inflammatory protein-1, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J Immunol. 2000;164:2650\u20139.","journal-title":"J Immunol"},{"key":"381_CR27","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.rmed.2005.11.009","volume":"100","author":"C Calabrese","year":"2006","unstructured":"Calabrese C, Bocchino V, Vatrella A, Marzo C, Guarino C, Mascitti S, Tranfa CME, Cazzola M, Micheli P, Caputi M, Marsico SA. Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction. Resp Med. 2006;100:1415\u201322.","journal-title":"Resp Med"},{"key":"381_CR28","first-page":"L278","volume":"266","author":"S Becker","year":"1994","unstructured":"Becker S, Quay J, Koren S. Constitutive and stimulated MCP-1, GRO and expression in human airway epithelium and broncho alveolar macrophages. Am J Phys. 1994;266:L278\u201386.","journal-title":"Am J Phys"},{"key":"381_CR29","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/thorax.57.7.590","volume":"57","author":"SL Traves","year":"2002","unstructured":"Traves SL, Culpitt SV, Russell REK, Barnes PJ, Donnelly LE. Increased levels of the chemokines GRO-\u03b1 and MCP-1 in sputum samples from patients with COPD. Thorax. 2002;57:590\u20135.","journal-title":"Thorax."},{"key":"381_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13104-018-3309-6","volume":"11","author":"G Elise","year":"2018","unstructured":"Elise G, George MI, C\u00e9line N, Walter P-YE, Martha M, Novel CN, Jacobs GB, Claire OAM. Chronic obstructive pulmonary disease (COPD): neutrophils, macrophages and lymphocytes in patients with anterior tuberculosis compared to tobacco related COPD. BMC Res Notes. 2018;11:192.","journal-title":"BMC Res Notes"},{"key":"381_CR31","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/cc10104","volume":"15","author":"L Leonardo","year":"2011","unstructured":"Leonardo L, Mart\u00edn M, Varo N, Borreguero-Le\u00f3n JM, Sol\u00e9-Viol\u00e1n J, Blanquer J, Labarta L, D\u00edaz C, Jim\u00e9nez A, Pastor E, Belmonte F, Orbe J, Rodr\u00edguez JA, G\u00f3mez-Melini E, Ferrer-Ag\u00fcero JM, Ferreres J, LLimi\u00f1ana MC, P\u00e1ramo JA. Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. Critical Care. 2011;15:R97.","journal-title":"Critical Care"},{"key":"381_CR32","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/01.CIR.0000088521.04017.13","volume":"108","author":"N Varo","year":"2003","unstructured":"Varo N, De Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schonbeck U. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation. 2003;108:1049\u201352.","journal-title":"Circulation."},{"key":"381_CR33","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0002-9343(02)01562-0","volume":"114","author":"H Kanzawa","year":"2003","unstructured":"Kanzawa H, Asai K, Hirata K, Yoshikawa J. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med. 2003;114:354\u20138.","journal-title":"Am J Med"},{"key":"381_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/thx.2004.023986","volume":"60","author":"AR Kranenburg","year":"2005","unstructured":"Kranenburg AR, De Boer WI, Alagappan VKT, Sterk PJ, Sharma HS. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:106\u201313.","journal-title":"Thorax."},{"issue":"6","key":"381_CR35","doi-asserted-by":"publisher","first-page":"e98440","DOI":"10.1371\/journal.pone.0098440","volume":"9","author":"A Sichelstiel","year":"2014","unstructured":"Sichelstiel A, Yadava K, Trompette A, Salami O, Iwakura Y, et al. Targeting IL-1b and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation. PLoS One. 2014;9(6):e98440. https:\/\/doi.org\/10.1371\/journal.pone.0098440.","journal-title":"PLoS One"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-020-00381-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-020-00381-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-020-00381-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T08:34:31Z","timestamp":1669019671000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-020-00381-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["381"],"URL":"https:\/\/doi.org\/10.1186\/s12865-020-00381-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21950\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21950\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21950\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21950\/v3","asserted-by":"object"}]},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"18 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The work received administrative approval from competent authorities at the YJH and ethical clearance from the Cameroon National Ethical Committee of Research for Human Health (N\u00b0 2016\/06\/772\/CE\/CNERSH\/SP). All participants included in the study gave written informed consent for participation, including consent for HIV testing.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}